NEW YORK (GenomeWeb News) — BioReliance has appointed David Onions CSO, effective June 18. Onions will run the company’s global clinical and preclinical scientific activities, the company said. Onions comes to BioReliance from Invitrogen, where he was CMO.

Millipore said Kathleen Allen is leaving her post as CFO, and has selected Charles Wagner to take her position.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.